tyrosine and ursodoxicoltaurine

tyrosine has been researched along with ursodoxicoltaurine in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lawless, MW; Mankan, AK; Norris, S; Ryan, AW	1
Almeida, MR; Batista, AR; Ferreira, N; Macedo, B; Saraiva, MJ	1
Dong, LQ; Fang, Q; Jia, W; Liu, F; Liu, M; Liu, X; Zhang, J; Zhou, L	1
Manrique, C; Neuringer, M; Padilla, J; Restaino, RM; Walsh, LK	1
He, Q; Jia, Z; Li, F; Shan, C	1

Trials

1 trial(s) available for tyrosine and ursodoxicoltaurine

Article	Year
Administration of tauroursodeoxycholic acid prevents endothelial dysfunction caused by an oral glucose load. Clinical science (London, England : 1979), 2016, 11-01, Volume: 130, Issue:21 Topics: Adult; Blood Glucose; Cardiovascular Diseases; Endoplasmic Reticulum Stress; Endothelium, Vascular; Female; Humans; Hyperglycemia; Insulin; Male; Oxidative Stress; Postprandial Period; Taurochenodeoxycholic Acid; Thiobarbituric Acid Reactive Substances; Tyrosine; Young Adult	2016

Article

Year

Administration of tauroursodeoxycholic acid prevents endothelial dysfunction caused by an oral glucose load.

Clinical science (London, England : 1979), 2016, 11-01, Volume: 130, Issue:21

Topics: Adult; Blood Glucose; Cardiovascular Diseases; Endoplasmic Reticulum Stress; Endothelium, Vascular; Female; Humans; Hyperglycemia; Insulin; Male; Oxidative Stress; Postprandial Period; Taurochenodeoxycholic Acid; Thiobarbituric Acid Reactive Substances; Tyrosine; Young Adult

2016

Other Studies

4 other study(ies) available for tyrosine and ursodoxicoltaurine

Article	Year
Tauroursodeoxycholic acid: relieving the pathogenesis of HFE C282Y hereditary hemochromatosis. Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:1 Topics: Antioxidants; Cysteine; Endoplasmic Reticulum; Hemochromatosis; Hemochromatosis Protein; Histocompatibility Antigens Class I; Homozygote; Humans; Membrane Proteins; Mutation; Reactive Oxygen Species; Taurochenodeoxycholic Acid; Tyrosine	2008
Anti-apoptotic treatment reduces transthyretin deposition in a transgenic mouse model of Familial Amyloidotic Polyneuropathy. Biochimica et biophysica acta, 2008, Volume: 1782, Issue:9 Topics: Amyloid Neuropathies, Familial; Animals; Apoptosis; Disease Models, Animal; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; fas Receptor; Gastrointestinal Tract; Heat-Shock Proteins; Humans; Immunohistochemistry; Methionine; Mice; Mice, Transgenic; Molecular Chaperones; Mutant Proteins; Mutation; Oxidation-Reduction; Prealbumin; Protein Structure, Quaternary; Taurochenodeoxycholic Acid; Thermodynamics; Tyrosine	2008
Autophagy-mediated insulin receptor down-regulation contributes to endoplasmic reticulum stress-induced insulin resistance. Molecular pharmacology, 2009, Volume: 76, Issue:3 Topics: 3T3-L1 Cells; Adipocytes; Animals; Autophagy; Disease Models, Animal; Down-Regulation; Endoplasmic Reticulum; Humans; Insulin Resistance; Leupeptins; Mice; Mice, Inbred Strains; Obesity; Phosphorylation; Receptor, Insulin; Taurochenodeoxycholic Acid; Tyrosine	2009
Tauroursodeoxycholic acid attenuates gentamicin-induced cochlear hair cell death in vitro. Toxicology letters, 2018, Sep-15, Volume: 294 Topics: Animals; Anti-Bacterial Agents; Apoptosis; Biomarkers; Cell Line; Cell Survival; Cochlea; Endoplasmic Reticulum Stress; Gene Expression Regulation; Gentamicins; Hair Cells, Auditory; Hearing Loss, Sensorineural; Humans; Mice, Inbred BALB C; Microscopy, Electron, Scanning; Nitric Oxide Synthase Type II; Protective Agents; Protein Processing, Post-Translational; Protein Synthesis Inhibitors; Taurochenodeoxycholic Acid; Tissue Culture Techniques; Tyrosine	2018